MMSI
Merit Medical Systems IncPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Available borrowing capacity | $697M | Q1 FY2026 | — |
| free cash flow non-GAAP | $25M | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MMSI
this stock
Merit Medical Systems Inc
|
$4.28B | -16.7% | +11.8% | 30.9 | 5.7% |
|
ISRG
Intuitive Surgical Inc
|
$144.30B | -28.2% | +20.5% | 49.5 | 2.1% |
|
MDLN
Medline Inc.
|
$53.91B | -2.3% | +11.5% | — | 2.8% |
|
BDX
Becton Dickinson & Co
|
$41.87B | +0.2% | +8.2% | 57.7 | 4.1% |
|
ALC
Alcon Inc
|
$33.07B | -14.8% | +10.5% | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MMSI | +3.3% | +9.6% | -8.6% | +5.9% | -16.7% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +2.5% | +7.6% | -17.5% | +5.3% | -26.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.